1 to 10 of 1,282 trials

• Etanercept for the Treatment of Lupus Nephritis

  conditions:	Lupus Nephritis
  interventions:	Etanercept ; Lupus Treatment
  last updated:	2009 Mar 27
  status:	recruiting
  sponsor:	National Institute of Allergy and Infectious Diseases (NIAID)

   

• To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

  conditions:	Lupus
  interventions:	Prasterone (GL701)
  last updated:	2007 Dec 26
  status:	active, not recruiting
  sponsor:	Genelabs Technologies

   

• Improving Quality of Life for African American Female Adolescents With Lupus

  conditions:	Lupus
  interventions:	Coping skills and cognitive restructuring techniques ; Educational training
  last updated:	2009 Apr 8
  status:	completed
  sponsor:	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

   

• Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)

  conditions:	Lupus
  interventions:	MEDI-545 ; MEDI 545 ; MEDI-545 ; MEDI-545 ; MEDI-545
  last updated:	2007 Dec 17
  status:	completed
  sponsor:	MedImmune LLC

   

• Disease Progression and Activity in Patients With Systemic Lupus Erythematosus

  conditions:	Lupus
  interventions:	none
  last updated:	2008 Mar 5
  status:	completed
  sponsor:	National Institute of Environmental Health Sciences (NIEHS)

   

• A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus

  conditions:	Lupus
  interventions:	MEDI 545 ; Placebo
  last updated:	2009 Jul 24
  status:	active, not recruiting
  sponsor:	MedImmune LLC

   

• Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies

  conditions:	Lupus
  interventions:	none
  last updated:	2009 Feb 24
  status:	recruiting
  sponsor:	University of California, San Francisco

   

• Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus

  conditions:	Lupus
  interventions:	none
  last updated:	2009 Feb 24
  status:	active, not recruiting
  sponsor:	University of California, San Francisco

   

• A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus

  conditions:	Lupus
  interventions:	MEDI-545 ; MEDI-545 ; MEDI-545 ; MEDI-545 ; Placebo
  last updated:	2009 Jun 24
  status:	recruiting
  sponsor:	MedImmune LLC

   

• Duke Lupus Registry

  conditions:	Systemic Lupus Erythematosus ; Cutaneous Lupus
  interventions:	none
  last updated:	2008 Aug 13
  status:	recruiting
  sponsor:	Duke University